Medtronic Q4 FY26 — revenue $9.81B (+9.9% rep / +6.6% organic) tops $9.73B est; non-GAAP EPS <meta name="viewport" content="width=device-width, initial-scale=1.0" />.55 in line; FY26 +5.8% organic is highest annual revenue growth in 10 years; raises dividend for 49th straight year and guides FY27 EPS $5.90

.55 in line; FY26 +5.8% organic is highest annual revenue growth in 10 years; raises dividend for 49th straight year and guides FY27 EPS $5.90–6.00; MDT +~1.4% premarket on June 3" /> .55 in line; FY26 +5.8% organic is highest annual revenue growth in 10 years; raises dividend for 49th straight year and guides FY27 EPS $5.90–6.00; MDT +~1.4% premarket on June 3" />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.